The impact of the Ebola crisis on mortality and welfare in Liberia

Costa, Shaun Da

doi:10.1002/hec.4150

Cited by 4 publications

(2 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Health impacts usually refer to welfare losses caused by serious threats to family members' health within a speci c time period (Bairoliya et al, 2018;Da Costa, 2020;Nam et al, 2010). Among various risk impacts, health impacts are central and key factors leading to household poverty, with short-term impacts on households far outweighing long-term ones, making them susceptible to temporary (Araujo & Coelho, 2021; L. J.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Impact, Medical Insurance System, and Health Equity

Qin,

Zhu,

et al. 2024

Preprint

View full text Add to dashboard Cite

Background The widespread outbreak of the COVID-19 pandemic poses a significant threat to human health. In the context of Healthy China, enhancing residents' health performance is an inevitable choice to promote the equalization of public medical and health services. Methods This article utilized online survey data, employs the O-probit model and Health Equity Gap Model to empirically analyze the relationship between COVID-19 infection, the medical insurance system, and health equity. Results Findings revealed that as of mid-January 2023, the nationwide infection rate of COVID-19 in China is 82.34%, with 24.86% of respondents reporting the loss of relatives or friends, and the average age of death being 71.30 years old. In terms of impact of COVID-19, Chinese residents are most concerned about the future impact of COVID-19 on their health and work. Compared to the Urban-Rural Resident Medical Insurance in China, the Urban Employee Medical Insurance is more effective in alleviating the negative impact of COVID-19 infection on residents' health, especially for middle-aged and elderly individuals, rural residents, those with chronic diseases, and in the eastern regions of China. Urban Employee Medical Insurance improves residents' health by influencing their drug purchase amount and outpatient visits following the impact of COVID-19. If Chinese residents receive the same treatment as Urban Employee Medical Insurance, their health would improve by 0.240 units, equivalent to 56.21% of the actual health gap between different medical insurance coverage groups. Conclusions Compared to the Urban-Rural Resident Medical Insurance, the Urban Employee Medical Insurance is more effective in mitigating the negative impact of COVID-19 infection on residents' health. Under the impact of the COVID-19 pandemic, different medical insurance systems have widened the health gap between urban employees and rural residents.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19 Impact, Medical Insurance System, and Health Equity

Qin,

Zhu,

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Similarly, Ebola viruses have a major impact on our society, causing a significant number of mortalities. Ebola viruses are highly lethal and have an average mortality rate of 50% [ 2 , 3 ]. Fortunately, vaccines have proven to be effective to protect humans from SARS-CoV-2 and Ebola virus (EBOV) infections [ 4 , 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses

Verma

et al. 2022

Pharmaceuticals

View full text Add to dashboard Cite

The rapid mutations of viruses such as SARS-CoV-2 require vaccine updates and the development of novel antiviral drugs. This article presents an improved database filtering technology for a more effective design of novel antiviral agents. Different from the previous approach, where the most probable parameters were obtained stepwise from the antimicrobial peptide database, we found it possible to accelerate the design process by deriving multiple parameters in a single step during the peptide amino acid analysis. The resulting peptide DFTavP1 displays the ability to inhibit Ebola virus. A deviation from the most probable peptide parameters reduces antiviral activity. The designed peptides appear to block viral entry. In addition, the amino acid signature provides a clue to peptide engineering to gain cell selectivity. Like human cathelicidin LL-37, our engineered peptide DDIP1 inhibits both Ebola and SARS-CoV-2 viruses. These peptides, with broad antiviral activity, may selectively disrupt viral envelopes and offer the lasting efficacy required to treat various RNA viruses, including their emerging mutants.

show abstract